Nelly Devuyst Ph Toner Bioacne
NDC Package 71447-007-01
Package Information
Nelly Devuyst Ph Toner Bioacne is ▪ For new users: apply product to a small area once to test if you are sensitive to this product.▪ If no discomfort occurs, after cleansing and or exfoliating, moisten a cotton pad with toner and apply to face and neck using upward movements, avoiding the eye area.▪ If bothersome dryness, irritation or peeling occurs, reduce application to every other day. Marketed by Laboratoires Druide Inc, this product is identified by NDC 71447-007 and is authorized under FDA application part333D.
Identification & Billing
- RxCUI: 199308 - salicylic acid 0.5 % Topical Solution
- RxCUI: 199308 - salicylic acid 5 MG/ML Topical Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 71447 - Laboratoires Druide Inc
- 71447-007 - Nelly Devuyst Ph Toner Bioacne
- 71447-007-01 - 1 BOTTLE, SPRAY in 1 CARTON / 500 mL in 1 BOTTLE, SPRAY
- 71447-007 - Nelly Devuyst Ph Toner Bioacne
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (71447-007). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71447-007-01 identifies a specific commercial package of 1 bottle, spray in 1 carton / 500 ml in 1 bottle, spray of Nelly Devuyst Ph Toner Bioacne, labeled by Laboratoires Druide Inc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Laboratoires Druide Inc on May 26, 2018. The current certification is valid through December 31, 2021.
How is this Laboratoires Druide Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71447000701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.